Pepgen Stock Today
| PEPG Stock | USD 1.71 0.58 25.33% |
PerformanceVery Weak
| Odds Of DistressHigh
|
PepGen is trading at 1.71 as of the 25th of February 2025. This is a 25.33 percent decrease since the beginning of the trading day. The stock's lowest day price was 1.68. PepGen has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 27th of November 2024 and ending today, the 25th of February 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 6th of May 2022 | Category Healthcare | Classification Health Care |
PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company was founded in 2018 and is headquartered in Cambridge, Massachusetts. The company has 32.6 M outstanding shares of which 675.58 K shares are at this time shorted by private and institutional investors with about 3.41 trading days to cover. More on PepGen
Moving against PepGen Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
PepGen Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Biotechnology, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsPepGen can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand PepGen's financial leverage. It provides some insight into what part of PepGen's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||
PepGen (PEPG) is traded on NASDAQ Exchange in USA. It is located in 321 Harrison Avenue, Boston, MA, United States, 02118 and employs 76 people. PepGen is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 74.64 M. PepGen conducts business under Biotechnology sector and is part of Health Care industry. The entity has 32.6 M outstanding shares of which 675.58 K shares are at this time shorted by private and institutional investors with about 3.41 trading days to cover.
PepGen currently holds about 218.82 M in cash with (69 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.26, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check PepGen Probability Of Bankruptcy
Ownership AllocationPepGen owns a total of 32.6 Million outstanding shares. The majority of PepGen outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in PepGen to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in PepGen. Please pay attention to any change in the institutional holdings of PepGen as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check PepGen Ownership Details
PepGen Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Hhg Plc | 2024-12-31 | 522.3 K | |
| Geode Capital Management, Llc | 2024-12-31 | 372.9 K | |
| State Street Corp | 2024-12-31 | 322.9 K | |
| Northern Trust Corp | 2024-12-31 | 157 K | |
| Millennium Management Llc | 2024-12-31 | 156.6 K | |
| Jacobs Levy Equity Management, Inc. | 2024-12-31 | 136.3 K | |
| Opaleye Management Inc | 2024-12-31 | 110 K | |
| Bridgeway Capital Management, Llc | 2024-12-31 | 98.9 K | |
| Goldman Sachs Group Inc | 2024-12-31 | 98.3 K | |
| Ra Capital Management, Llc | 2024-12-31 | 10.7 M | |
| Rtw Investments, Llc | 2024-12-31 | 3.2 M |
PepGen Historical Income Statement
PepGen Stock Against Markets
PepGen Corporate Management
| James McArthur | CEO and President | Profile | |
| Caroline Godfrey | Founder Member | Profile | |
| MBA CFA | Senior Communications | Profile | |
| Afsaneh Mohebbi | Senior Management | Profile | |
| Michelle MD | Senior Development | Profile | |
| David CFA | Senior Communications | Profile | |
| Jaya Goyal | Executive Development | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PepGen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For more detail on how to invest in PepGen Stock please use our How to Invest in PepGen guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PepGen. If investors know PepGen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PepGen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of PepGen is measured differently than its book value, which is the value of PepGen that is recorded on the company's balance sheet. Investors also form their own opinion of PepGen's value that differs from its market value or its book value, called intrinsic value, which is PepGen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PepGen's market value can be influenced by many factors that don't directly affect PepGen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PepGen's value and its price as these two are different measures arrived at by different means. Investors typically determine if PepGen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PepGen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.